Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion type Assertion NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_head.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion description "[Comparing tumours with low expression of CLDN3, CLDN4 and CLDN7 with tumours previously referred to as CLDN-low by genomic assays, we demonstrated that the single IHC evaluation of these three specific CLDNs is insufficient to identify the CLDN-low molecular subtype of breast tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion evidence source_evidence_literature NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion SIO_000772 22936447 NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion wasDerivedFrom befree-2016 NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.
- NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_assertion wasGeneratedBy ECO_0000203 NP1009276.RAsYTWo6kNe2ureiMzBH1xaa-JVr23OA2j0peRLUTstdM130_provenance.